Biogen

Biogen is a global biotechnology company that focuses on the development of therapies for neurological disorders, autoimmune diseases, and rare genetic conditions. The company was founded in 1978 and has since become known for its research and development in the field of neuroscience. Biogen's drug portfolio includes treatments for multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease. The company's innovative therapies aim to address the underlying mechanisms of these diseases and improve patient outcomes.